These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differentiating pancreatic cystic neoplasms from pancreatic pseudocysts at MR imaging: value of perceived internal debris. Macari M, Finn ME, Bennett GL, Cho KC, Newman E, Hajdu CH, Babb JS. Radiology; 2009 Apr; 251(1):77-84. PubMed ID: 19332847 [Abstract] [Full Text] [Related]
9. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. Kelekis NL, Semelka RC, Worawattanakul S, de Lange EE, Ascher SM, Ahn IO, Reinhold C, Remer EM, Brown JJ, Bis KG, Woosley JT, Mitchell DG. AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051 [Abstract] [Full Text] [Related]
10. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI. Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319 [Abstract] [Full Text] [Related]
11. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard. Hardie AD, Kizziah MK, Rissing MS. J Comput Assist Tomogr; 2011 Feb; 35(6):711-5. PubMed ID: 22082541 [Abstract] [Full Text] [Related]
12. Gadolinium-enhanced MR imaging of temporomandibular disorders: improved lesion detection of the posterior disk attachment on T1-weighted images obtained with fat suppression. Suenaga S, Abeyama K, Noikura T. AJR Am J Roentgenol; 1998 Aug; 171(2):511-7. PubMed ID: 9694485 [Abstract] [Full Text] [Related]
13. Incidental pancreatic cysts: natural history and diagnostic accuracy of a limited serial pancreatic cyst MRI protocol. Nougaret S, Reinhold C, Chong J, Escal L, Mercier G, Fabre JM, Guiu B, Molinari N. Eur Radiol; 2014 May; 24(5):1020-9. PubMed ID: 24569848 [Abstract] [Full Text] [Related]
15. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid. Kim KA, Kim MJ, Park MS, Lim JS, Choi JY, Hong HS, Kim KW. Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837 [Abstract] [Full Text] [Related]
16. Diffusion-weighted MRI in the characterization of cystic pancreatic lesions: usefulness of ADC values. Boraschi P, Donati F, Gigoni R, Salemi S, Bartolozzi C, Falaschi F. Magn Reson Imaging; 2010 Dec; 28(10):1447-55. PubMed ID: 20864287 [Abstract] [Full Text] [Related]
19. Contrast-enhanced MR enterography as a stand-alone tool to evaluate Crohn's disease in a paediatric population. Spieler B, Hindman N, Levy J, Zabrieski K, Sahlein D, Seuss C, Kim S. Clin Radiol; 2013 Oct; 68(10):1024-30. PubMed ID: 23796211 [Abstract] [Full Text] [Related]
20. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M. Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184 [Abstract] [Full Text] [Related] Page: [Next] [New Search]